CMIP促进人结直肠癌对阿霉素耐药性的机制研究
作者:
作者单位:

1.安徽医科大学附属巢湖医院 肿瘤内科,安徽 巢湖,238000;2.淮北市人民医院 普外科,安徽 淮北,235100

作者简介:

周丽,女,硕士,主治医师,研究方向:胃肠、甲状腺、乳腺等恶性肿瘤。

通讯作者:

周大新,男,硕士,主任医师,硕士生导师,研究方向:胃肠、甲状腺、乳腺等恶性肿瘤。

中图分类号:

R735.3

基金项目:

安徽省高等学校自然科学研究项目重大项目(KJ2021A0738)。


Mechanism of CMIP promoting drug resistance to doxorubicin in human colon cancer
Author:
Affiliation:

1.Department of Oncology, Chaohu Hospital Affiliated to Anhui Medical University, Chaohu, 238000, Anhui, China;2.Department of General Surgery, Huaibei People's Hospital, Huaibei, 235100, Anhui, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨CMIP对人结直肠癌阿霉素耐药性的影响。方法 收集淮北市人民医院2021年1月—2022年12月60例结直肠癌患者的癌组织标本和癌旁正常组织标本,免疫组化检测CMIP在结直肠癌组织中的表达,分析CMIP与结直肠癌临床病理特征的相关性。采用CCK8实验检测人结直肠癌HCT116、HT29细胞株的细胞增殖活力,并采用细胞划痕实验检测细胞迁移能力。运用catRAPID omics v2.0网站预测CMIP的潜在互作靶点,通过Metascape网站对CMIP的靶基因进行GO功能和KEGG通路富集分析。结果 CMIP在结直肠癌组织中呈高表达,CMIP表达与结直肠癌临床病理特征存在相关性。过表达/敲低CMIP可促进/抑制结直肠癌细胞的增殖和迁移,过表达/敲低CMIP可促进/抵抗结直肠癌阿霉素耐药。通过catRAPID omics v2.0数据库共发现205个CMIP相关mRNA,GO和KEGG分析结果显示,CMIP可能通过多种生物学过程和信号通路介导结直肠癌阿霉素耐药。结论 CMIP可促进结直肠癌的发展和阿霉素耐药,具体作用机制还需进一步研究。

    Abstract:

    Objective To investigate the effects of C-Maf inducing protein (CMIP) on doxorubicin resistance in human colorectal cancer.Methods Sixty cases of colorectal cancer tissues and 60 cases of adjacent normal tissues were collected from Huaibei People's Hospital from January 2021 to December 2022. The expression of CMIP in colorectal cancer tissues was detected by immunohistochemistry, and the correlation between CMIP and clinicopathological characteristics of colorectal cancer was analyzed. Proliferation and migration of human colorectal cancer HCT116 and HT29 cell lines were assessed using CCK8 assay and cell scratch assay, respectively. Potential interacting targets of CMIP were predicted using the catRAPID omics v2.0 website. The GO function and KEGG pathway enrichment analysis of the target genes of CMIP were performed by Metascape website.Results The expression of CMIP was upregulated in human colorectal cancer tissues, and was correlated with the clinicopathological features of colorectal cancer. Overexpression/knockdown of CMIP promoted/inhibited proliferation and migration of colorectal cancer cells, as well as enhanced/resisted adriamycin resistance in these cells. A total of 205 CMIP-related mRNAs were found by catRAPID omics v2.0 database. GO and KEGG analysis results indicated that CMIP may mediate doxorubicin resistance in colorectal cancer through multiple biological processes and signaling pathways.Conclusion CMIP can facilitate the development of colorectal cancer and its resistance to doxorubicin. However, further investigation is required to elucidate its specific mechanism.

    参考文献
    相似文献
    引证文献
引用本文

周丽,周大新,谢方利,李祥兵. CMIP促进人结直肠癌对阿霉素耐药性的机制研究[J].肿瘤药学,2024,14(3):271-277 ( in Chinese)

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-10-22
  • 出版日期:
我要投稿 杂志简介 杂志简介 二维码
TOP
×
《肿瘤药学》
《肿瘤药学》编辑部打假维权声明